| Baseline | One month after treatment | Three month after treatment |
---|---|---|---|
PLI | |||
 Adults | 0.195 ± 0.311a | 0.610 ± 0.512* | 0.780 ± 0.531* |
 Adolescents | 0.491 ± 0.367 | 0.637 ± 0.444* | 0.899 ± 0.490* |
 Total | 0.345 ± 0.292 | 0.680 ± 0.463* | 0.876 ± 0.462* |
SBI | |||
 Adults | 0.253 ± 0.412 | 1.123 ± 0.503* | 1.119 ± 0.148* |
 Adolescents | 0.278 ± 0.457 | 0.993 ± 0.492* | 1.002 ± 0.481* |
 Total | 0.283 ± 0.505 | 0.976 ± 0.0.484* | 0.984 ± 0.0.496*,# |
PD | |||
 Adults | 0.056 ± 0.122a | 1.188 ± 0.164* | 1.047 ± 0.148* |
 Adolescents | 1.015 ± 0.101 | 1.190 ± 0.172* | 1.021 ± 0.104* |
 Total | 1.020 ± 0.103 | 1.178 ± 0.180 | 1.100 ± 0.0.142*,# |